Incidence of tozinameran adverse events among the employees of National Cancer Institute.

被引：1
|
作者：
Palacka, Patrik
Slopovsky, Jan
Zanchetta, Katarina
Drgona, Lubos
Badurikova, Eva
Bernadicova, Beata
Baranova, Vladimira
Pechan, Juraj
Mego, Michal
机构：
[1] Comenius Univ, Dept Oncol 2, Fac Med, Bratislava, Slovakia
[2] Natl Canc Inst, Bratislava, Slovakia
[3] Univ Trnava, Fac Hlthcare & Social Work, Dept Nursing, Bratislava, Slovakia
[4] Natl Canc Inst, Bratislava, Slovakia
[5] Comenius Univ, Fac Med, Dept Oncohematol, Bratislava, Slovakia
[6] Slovak Med Univ, Dept Surg Oncol, Bratislava, Slovakia
[7] St Elizabeth Univ Hlth & Social Sci, Bratislava, Slovakia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
Tozinameran; Active Immunization; COVID-19; Healthcare Professionals; Adverse Events;
D O I：
10.1200/JCO.2021.39.15_suppl.e18724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18724
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cover legend: National Cancer Institute.
    不详
    [J]. ONCOLOGY REPORTS, 1999, 6 (06) : 1179 - 1179
  • [2] Survivorship model of care at a large National Cancer Institute.
    Pabbathi, Smitha
    Morgan, Mary Ann
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [3] Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute.
    Hance, KW
    Anderson, WF
    Devesa, SS
    Levine, PH
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S148 - S148
  • [4] Cervical cancer in young patients: Experience from the Peruvian National Cancer Institute.
    Mendoza, Rossana Esther Ruiz
    Cardoso, Mariana Serrano
    Mantilla, Raul
    Valdiviezo, Natalia
    Olivera, Mivael
    Mas, Luis
    Gomez, Henry Leonidas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] AIDS Malignancy Program: New initiatives from the National Cancer Institute.
    Feigal, EG
    Wu, RS
    Ungerleider, RS
    Wittes, RE
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : 58 - 58
  • [6] The Canadian Adverse Events Study:: the incidence of adverse events among hospital patients in Canada
    Baker, GR
    Norton, PG
    Flintoft, V
    Blais, R
    Brown, A
    Cox, J
    Etchells, E
    Ghali, WA
    Hébert, P
    Majumdar, SR
    O'Beirne, M
    Palacios-Derflingher, L
    Reid, RJ
    Sheps, S
    Tamblyn, R
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (11) : 1678 - 1686
  • [7] Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events
    Zhong, Xiaobo
    Lim, Emerson A.
    Hershman, Dawn L.
    Moinpour, Carol M.
    Unger, Joseph
    Lee, Shing M.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (03) : E270 - E280
  • [8] Assessment of adverse events among cervical cancer patients at Kenyatta National Hospital
    Kibaara, Muthoni
    Degu, Amsalu
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, : 326 - 332
  • [9] The incidence of adverse events among home care patients
    Sears, Nancy
    Baker, G. Ross
    Barnsley, Jan
    Shortt, Sam
    [J]. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2013, 25 (01) : 16 - 28
  • [10] Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events
    Aranaz-Andres, J. M.
    Aibar-Remon, C.
    Vitaller-Murillo, J.
    Ruiz-Lopez, P.
    Limon-Ramirez, R.
    Terol-Garcia, E.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2008, 62 (12) : 1022 - 1029
12345